D&D Pharmatech (347850.KQ)

KRW 47200.0

(0.21%)

Gross Profit Summary of D&D Pharmatech

D&D Pharmatech's latest annual gross profit in 2023 was 18.67 Billion KRW , up 3120.88% from previous year.
D&D Pharmatech's latest quarterly gross profit in 2024 Q2 was 2.31 Billion KRW , up 4.5% from previous quarter.
D&D Pharmatech reported a annual gross profit of 579.21 Million KRW in annual gross profit 2022, down -56.71% from previous year.
D&D Pharmatech reported a annual gross profit of 1.33 Billion KRW in annual gross profit 2021, up 3207.27% from previous year.
D&D Pharmatech reported a quarterly gross profit of 2.21 Billion KRW for 2024 Q1, up 23.06% from previous quarter.
D&D Pharmatech reported a quarterly gross profit of 1.8 Billion KRW for 2023 Q4, down -74.25% from previous quarter.

Annual Gross Profit Chart of D&D Pharmatech (2023 - 2019)

Historical Annual Gross Profit of D&D Pharmatech (2023 - 2019)

Year	Gross Profit	Gross Profit Growth
2023	18.67 Billion KRW	3120.88%
2022	579.21 Million KRW	-56.71%
2021	1.33 Billion KRW	3207.27%
2020	-43.06 Million KRW	-209.3%
2019	-13.92 Million KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	2.31 Billion KRW	4.5%
2024 Q1	2.21 Billion KRW	23.06%
2023 Q4	1.8 Billion KRW	-74.25%
2023 FY	18.67 Billion KRW	3124.57%
2023 Q3	6.99 Billion KRW	-27.91%
2023 Q2	9.7 Billion KRW	96.76%
2023 Q1	4.93 Billion KRW	3679.74%
2022 FY	579.21 Million KRW	-56.71%
2022 Q4	130.48 Million KRW	0.0%
2021 FY	1.33 Billion KRW	3207.27%
2020 FY	-43.06 Million KRW	-209.3%
2019 FY	-13.92 Million KRW	0.0%

Peer Gross Profit Comparison of D&D Pharmatech

Name	Gross Profit	Gross Profit Difference
HLB Co., Ltd.	-6.01 Billion KRW	410.638%
iNtRON Biotechnology, Inc.	4.56 Billion KRW	-309.506%
BINEX Co., Ltd.	56.65 Billion KRW	67.034%
Bioneer Corporation	199.25 Billion KRW	90.626%
Anterogen.Co.,Ltd.	2.21 Billion KRW	-743.801%
MEDIPOST Co., Ltd.	40.18 Billion KRW	53.521%
CrystalGenomics, Inc.	1.45 Billion KRW	-1181.878%
Helixmith Co., Ltd	2.12 Billion KRW	-780.224%
Chabiotech Co.,Ltd.	255.19 Billion KRW	92.681%
Medy-Tox Inc.	128.16 Billion KRW	85.427%
Peptron, Inc.	1.14 Billion KRW	-1537.505%
Amicogen, Inc.	51.51 Billion KRW	63.743%
Genexine, Inc.	387.48 Million KRW	-4720.069%
HLB Therapeutics Co.,Ltd.	6.69 Billion KRW	-179.001%
LegoChem Biosciences, Inc.	17.79 Billion KRW	-4.943%
ALTEOGEN Inc.	31.19 Billion KRW	40.135%
PharmaResearch Co., Ltd.	182.25 Billion KRW	89.752%
SillaJen, Inc.	1.45 Billion KRW	-1182.109%
JETEMA, Co., Ltd.	26.58 Billion KRW	29.738%
OliX Pharmaceuticals,Inc	14.42 Billion KRW	-29.501%
Genomictree Inc.	-1.03 Billion KRW	1898.301%
MedPacto, Inc.	-1.83 Billion KRW	1119.119%
EASY BIO,Inc.	50.88 Billion KRW	63.296%
GI Innovation, Inc.	1.98 Billion KRW	-838.817%